Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023.
Unaudited Financial Results for the quarter and nine months ended December 31, 2023.08-02-2024
08-02-2024
Windlas Biotech Ltd - 543329 - Financial Results For The Quarter And Nine Months Ended December 31, 2023.
Financial Results for the quarter and nine months ended December 31, 2023.08-02-2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
To discuss financial performance for quarter ended December 31, 202330-01-2024
Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Thursday, The February 8, 2024
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 8, 2024, inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2023.30-01-2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201512-01-2024
Windlas Biotech Ltd - 543329 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI DP Regulation, 2018 for the Quarter ended December 31, 2023.09-01-2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201505-01-2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201504-01-2024
Windlas Biotech Ltd - 543329 - Closure of Trading Window
Intimation of closure of Trading Window30-12-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201512-12-2023